| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/27/2003 | US20030038828 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038827 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038826 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038081 For microfiltration and ultrafiltration; membranes are internally hydrophilic; separation of proteins from liquids such as milk |
| 02/27/2003 | CA2458890A1 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | CA2458648A1 Secreted proteins |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2457850A1 Novel amylases and uses thereof |
| 02/27/2003 | CA2457632A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | CA2457461A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 02/27/2003 | CA2457330A1 Oral immunoglobulin treatment for inflammatory bowel disease |
| 02/27/2003 | CA2457328A1 Agents for enhancing the immune response |
| 02/27/2003 | CA2457143A1 In situ immunization |
| 02/27/2003 | CA2457065A1 Periostin-based diagnostic assays |
| 02/27/2003 | CA2456470A1 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | CA2454879A1 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | CA2454856A1 High strength asymmetric cellulosic membrane |
| 02/27/2003 | CA2452104A1 Use of antibodies having high affinity for soluble ass to treat conditions and diseases related to ass |
| 02/27/2003 | CA2451998A1 Anti-a.beta. antibodies |
| 02/27/2003 | CA2436426A1 Anti-ciguatoxin monoclonal antibody |
| 02/26/2003 | WO2003009870A1 Remedies for mammary cancer |
| 02/26/2003 | EP1285964A2 Human Mater proteins |
| 02/26/2003 | EP1285930A2 Human antibodies that bind human TNFalpha |
| 02/26/2003 | EP1285664A2 Methods of increasing lean tissue mass using OB protein compositions |
| 02/26/2003 | EP1285577A1 Chimeric mouse having an immune system constructed with human cd34-positive cells and use thereof |
| 02/26/2003 | EP1285272A2 Compositions and methods for screening therapeutic agents |
| 02/26/2003 | EP1285270A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285074A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/26/2003 | EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators |
| 02/26/2003 | EP1285068A2 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 02/26/2003 | EP1285066A1 F-box containing protein |
| 02/26/2003 | EP1285065A2 Long wavelength engineered fluorescent proteins |
| 02/26/2003 | EP1285054A1 Process for binding an antigen to a molecule having a high binding affinity to said antigen |
| 02/26/2003 | EP1284998A2 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 02/26/2003 | EP1284997A2 Therapeutic compounds for ovarian cancer |
| 02/26/2003 | EP1284996A2 Therapeutic anti-melanoma compounds |
| 02/26/2003 | EP1284995A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 02/26/2003 | EP1284993A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 02/26/2003 | EP1284989A1 Separation of avian antibodies |
| 02/26/2003 | EP1284752A1 Bispecific molecules and uses thereof |
| 02/26/2003 | EP1284751A1 Compositions and methods for induction of active autoimmunity |
| 02/26/2003 | EP1019423B1 Method for producing a pentopyranosyl nucleoside |
| 02/26/2003 | EP0910407B1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 02/26/2003 | EP0759943B1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof |
| 02/26/2003 | CN1399722A Compositions and Methods for detecting treponema pallidum |
| 02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
| 02/26/2003 | CN1399646A Recombinant fusion molecules |
| 02/26/2003 | CN1399645A Human monolonal antibodies to HER2/NEU |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399557A Remedies for drug-resistant hypercalcemia |
| 02/26/2003 | CN1399556A APRIL receptor (BCMA) and uses thereof |
| 02/26/2003 | CN1399554A Method and compositions for inhibiting adhesion formation |
| 02/26/2003 | CA2454667A1 Remedies for mammary cancer |
| 02/25/2003 | USRE38008 Peptides hormones, steroid hormones and conjugates thereof are disclosed. Enhanced delivery to target cells of antibodies or fragments thereof or other receptor-mediated delivery system, such as peptide, specific for a population of cells of a |
| 02/25/2003 | US6525190 Amidase |
| 02/25/2003 | US6525187 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/25/2003 | US6525180 Antibodies to mammalian T cell surface antigen |
| 02/25/2003 | US6525179 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6525177 Truncated forms of NY-ESO-1 protein |
| 02/25/2003 | US6524865 Electrochemiluminescent enzyme immunoassay |
| 02/25/2003 | US6524819 And their use in the screening for compounds of use in characterization, diagnosis, and treatment of conditions such as Alzheimer's disease, Down syndrome and other forms of dementia |
| 02/25/2003 | US6524817 DNA encoding a receptor subunit for oncostatin M |
| 02/25/2003 | US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus |
| 02/25/2003 | US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 |
| 02/25/2003 | US6524802 Methods of detecting growth differentiation factor-14 |
| 02/25/2003 | US6524590 Immunoassay |
| 02/25/2003 | US6524583 Inhibit angiogenesis and induce tumor regression, and have improved safety due to their specificity |
| 02/25/2003 | US6524582 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6524581 Integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist. |
| 02/25/2003 | US6524579 Diagnosing, treating or preventing disorders associated with expression of RNABP, cancer, immune disorder, developmental disorders |
| 02/20/2003 | WO2003014960A2 Method of identifying a consensus sequence for intracellular antibodies |
| 02/20/2003 | WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/20/2003 | WO2003014728A1 Remedies for hepatitis c |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014391A2 Method for the detection of a polymorphism in cpb2 |
| 02/20/2003 | WO2003014353A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | WO2003014344A2 Expression of modified antibodies in avian cells |
| 02/20/2003 | WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014163A1 Anti-idiotypic antibodies of hla class i molecules and the use thereof in the preparation of compositions that are designed to inhibit vascular activation |
| 02/20/2003 | WO2003014162A1 ANTIBODY RECOGNIZING GM1 GANGLIOSIDE-BOUND AMYLOID β-PROTEIN AND DNA ENCODING THE ANTIBODY |
| 02/20/2003 | WO2003014161A2 Antigen binding domains from fish |
| 02/20/2003 | WO2003014159A1 Methods of screening based on the egf receptor crystal structure |
| 02/20/2003 | WO2003014153A2 Cellular virus receptors and methods of use. |
| 02/20/2003 | WO2003014151A2 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | WO2003014142A2 Phosphorylated histone h2b as an apoptosis marker |
| 02/20/2003 | WO2003013702A1 Separation of components from milk sources |
| 02/20/2003 | WO2003013603A1 Modulators of p-selectin glycoprotein ligand 1 |
| 02/20/2003 | WO2003013602A1 Inhibitors of her3 activity |
| 02/20/2003 | WO2003013601A1 Toxin associated with sudden infant death syndrome, and uses thereof |
| 02/20/2003 | WO2003013590A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 02/20/2003 | WO2003013577A2 Use of il-18 inhibitors in hypersensitivity disorders |
| 02/20/2003 | WO2003013485A1 Inhibitors of hb-egf (erbb) receptors for treating myeloma |
| 02/20/2003 | WO2003013431A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | WO2002096945A3 Macrophage receptor agonist or antagonist |
| 02/20/2003 | WO2002094874A3 Internalisation of virus into cells |
| 02/20/2003 | WO2002094862A3 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |